rs146292053

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001363118.2(SLC52A2):​c.1089G>A​(p.Pro363Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0056 in 1,604,502 control chromosomes in the GnomAD database, including 67 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0058 ( 11 hom., cov: 33)
Exomes 𝑓: 0.0056 ( 56 hom. )

Consequence

SLC52A2
NM_001363118.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -8.89

Publications

3 publications found
Variant links:
Genes affected
SLC52A2 (HGNC:30224): (solute carrier family 52 member 2) This gene encodes a membrane protein which belongs to the riboflavin transporter family. In humans, riboflavin must be obtained by intestinal absorption because it cannot be synthesized by the body. The water-soluble vitamin riboflavin is processed to the coenzymes flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) which then act as intermediaries in many cellular metabolic reactions. Paralogous members of the riboflavin transporter gene family are located on chromosomes 17 and 20. Unlike other members of this family, this gene has higher expression in brain tissue than small intestine. Alternative splicing of this gene results in multiple transcript variants encoding the same protein. Mutations in this gene have been associated with Brown-Vialetto-Van Laere syndrome 2 - an autosomal recessive progressive neurologic disorder characterized by deafness, bulbar dysfunction, and axial and limb hypotonia. [provided by RefSeq, Jul 2012]
SLC52A2 Gene-Disease associations (from GenCC):
  • Brown-Vialetto-van Laere syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 8-144360677-G-A is Benign according to our data. Variant chr8-144360677-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 385698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-8.89 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00576 (876/152088) while in subpopulation NFE AF = 0.0068 (462/67942). AF 95% confidence interval is 0.00629. There are 11 homozygotes in GnomAd4. There are 494 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 11 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001363118.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC52A2
NM_001363118.2
MANE Select
c.1089G>Ap.Pro363Pro
synonymous
Exon 4 of 5NP_001350047.1Q9HAB3
SLC52A2
NM_001253815.2
c.1089G>Ap.Pro363Pro
synonymous
Exon 4 of 5NP_001240744.1Q9HAB3
SLC52A2
NM_001253816.2
c.1089G>Ap.Pro363Pro
synonymous
Exon 4 of 5NP_001240745.1Q9HAB3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC52A2
ENST00000643944.2
MANE Select
c.1089G>Ap.Pro363Pro
synonymous
Exon 4 of 5ENSP00000496184.2Q9HAB3
SLC52A2
ENST00000329994.7
TSL:1
c.1089G>Ap.Pro363Pro
synonymous
Exon 4 of 5ENSP00000333638.2Q9HAB3
SLC52A2
ENST00000675787.1
c.1078G>Ap.Ala360Thr
missense
Exon 3 of 4ENSP00000502189.1A0A6Q8PGB9

Frequencies

GnomAD3 genomes
AF:
0.00576
AC:
876
AN:
151972
Hom.:
11
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000604
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00157
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.000194
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.0327
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00680
Gnomad OTH
AF:
0.00431
GnomAD2 exomes
AF:
0.00579
AC:
1405
AN:
242682
AF XY:
0.00565
show subpopulations
Gnomad AFR exome
AF:
0.000633
Gnomad AMR exome
AF:
0.00111
Gnomad ASJ exome
AF:
0.000508
Gnomad EAS exome
AF:
0.000110
Gnomad FIN exome
AF:
0.0349
Gnomad NFE exome
AF:
0.00598
Gnomad OTH exome
AF:
0.00619
GnomAD4 exome
AF:
0.00558
AC:
8111
AN:
1452414
Hom.:
56
Cov.:
45
AF XY:
0.00553
AC XY:
3998
AN XY:
722708
show subpopulations
African (AFR)
AF:
0.000628
AC:
21
AN:
33464
American (AMR)
AF:
0.00126
AC:
56
AN:
44616
Ashkenazi Jewish (ASJ)
AF:
0.000500
AC:
13
AN:
26008
East Asian (EAS)
AF:
0.000302
AC:
12
AN:
39682
South Asian (SAS)
AF:
0.00186
AC:
160
AN:
86122
European-Finnish (FIN)
AF:
0.0316
AC:
1444
AN:
45646
Middle Eastern (MID)
AF:
0.00243
AC:
14
AN:
5756
European-Non Finnish (NFE)
AF:
0.00547
AC:
6081
AN:
1110890
Other (OTH)
AF:
0.00515
AC:
310
AN:
60230
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
461
922
1382
1843
2304
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
224
448
672
896
1120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00576
AC:
876
AN:
152088
Hom.:
11
Cov.:
33
AF XY:
0.00664
AC XY:
494
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.000602
AC:
25
AN:
41504
American (AMR)
AF:
0.00157
AC:
24
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5146
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4822
European-Finnish (FIN)
AF:
0.0327
AC:
347
AN:
10596
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00680
AC:
462
AN:
67942
Other (OTH)
AF:
0.00427
AC:
9
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
41
81
122
162
203
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00641
Hom.:
4
Bravo
AF:
0.00314
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00540
EpiControl
AF:
0.00475

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
3
not specified (3)
-
-
1
Brown-Vialetto-van Laere syndrome 2 (1)
-
-
1
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
2.8
DANN
Benign
0.81
PhyloP100
-8.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146292053; hg19: chr8-145584337; COSMIC: COSV57351787; COSMIC: COSV57351787; API